Bicara Therapeutics Inc. Common Stock (BCAX) News

Latest headlines that mention BCAX, newest first · each headline opens the original publisher

BCAX quote

Last price: $10.73
Day change: +5.40%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

BCAX headlines

last 30 days

Investing.com 1d ago

Citizens reiterates Bicara Therapeutics stock rating on trial progress

General T3BCAX

Motley Fool 1d ago

Bicara (BCAX) Q3 2026 Earnings Call Transcript

Management outlines interim analysis timing and new survival data plans.

Earnings T3BCAX

Seeking Alpha 1d ago

Bicara plans mid-2027 interim analysis as $442.3M cash runway extends into first half of 2029

General T2BCAX

Seeking Alpha News 1d ago

Bicara Therapeutics Inc. (BCAX) Q3 2026 Earnings Call Transcript

Earnings T2BCAX

Seeking Alpha 2d ago

Bicara Therapeutics GAAP EPS of -$1.04 misses by $0.22

Earnings T2BCAX

Investing.com 12d ago

Goldman Sachs downgrades Bicara Therapeutics stock rating to sell

General T3BCAX GS

Also mentioned with BCAX

30d

Headlines that tag both tickers

BCAX news alerts

Get an alert by email or push when a new headline mentions BCAX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.